Extracorporeal adsorption of endotoxin

Therapeutic Apheresis

Volumn 1, Issue 1, 1997, Pages 67-74

  Staubach, Karl Hermann ^a   Rosenfeldt, Jörg André ^a   Veit, Otto ^b   Bruch, Hans Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b FRESENIUS AG   (Germany)

Author keywords

Cardiorespiratory function; Endotoxin adsorption; Endotoxin shock; Polymyxin B

Indexed keywords

ENDOTOXIN; MICROSPHERE; POLYMYXIN B;

ADSORPTION; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; EVALUATION; FEMALE; HEMOPERFUSION; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; PARTICLE SIZE; PATHOPHYSIOLOGY; SALMONELLA; SEPTIC SHOCK; SWINE; TIME;

ADSORPTION; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXINS; EVALUATION STUDIES; FEMALE; HEMOPERFUSION; MICROSPHERES; PARTICLE SIZE; POLYMYXIN B; SALMONELLA; SHOCK, SEPTIC; SWINE; TIME FACTORS;

EID: 0031061133     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00017.x     Document Type: Article

References (25)

1. Shapiro L, Gelfand JA. Cytokines and sepsis: Pathophysiology and therapy. New Horizons 1993;1:13-22.
2. Taviera da Silva AM, Kaulbach H, Chuidian F, Lambert DR, Suffredini AF, Danner RL. Brief report: Shock and multiple organ dysfunction caused by self-administration of Salmonella endotoxin. N Engl J Med 1993;328:1457-60.
3. Bone RC, Fischer CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA and the methylprednisolone severe sepsis study group. A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
4. VA Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-65.
5. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NNH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR and the HA-IA sepsis study group. Treatment of gram-negative bacteriemia and spetic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-36.
6. Greenman RL, Schein RMH, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G, Chmel H, Kohler RB, MacIntyre M, Plouffe J, Russel JA. A controlled clinical trial of E5 murine monoclonal antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991;266:1097-102.
7. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994;271:1836-43.
8. Dhainaut JF, Tenaillon A, LeTulzo Y, Schlemmer B, Solet JP, Wolff M, Holzapfel L, Zeni F, Dreyfuss D, Mira JP, De-Vathaire F, Guinot P. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Crit Care Med 1994;22:1720-8.
9. Christensen RE, Hill HR, Anstall HB, Rothstein G. Exchange transfusion as an alternative to granulocyte administration in neonates with bacterial sepsis and profound neutropenia. J Clin Apheresis 1984;2:177-83.
10. Bende S, Bertok L. Elimination of endotoxin from the blood by extracorporal activated charcoal hemoperfusion in experimental canine endotoxin shock. Circ Shock 1986;19:239-44.
11. Scharfmann WB, Tillotson JR, Taft EG, Wright E. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med 1979;300:1277-8.
12. Cohen J, Aslam M, Pusey CD, Ryan CJ. Protection from endotoxemia: A rat model of plasmapheresis and specific adsorption with polymyxin B. J Infect Dis 1987;155:690-5.
13. Hanasawa K, Tani T, Kodama M. New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 1989;168:323-31.
14. Bjorvatn B, Bjertnes L, Fadness HO, Flaegstad T, Gutteberg TJ, Kristiansen BE, Pappa J, Rekvik OP, Osterud B, Anderud L. Meningococcal septicemia treated with combined plasmapheresis and eucapheresis or with blood exchange. Br Med J 1984;288:439-41.
15. Corrigan JJ, Kiernat JF. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model. Pediatr Res 1979;13:48-51.
16. Wolinsky E, Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N Engl J Med 1962;266: 759-62.
17. Spencer PC, Schmidt B, Samtleben W, Bosch T, Gurland HJ. Ex vivo model of hemodialysis membrane biocompatibility. Trans ASAIO 1985;31:495-8.
18. Mathison JD, Ulevich RJ. The clearance, tissue distribution, and cellular localisation of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133-43.
19. Freudenberg N, Freudenberg MA, Bandara K, Galanos C. Distribution and localization of endotoxin in the reticuloendothelial system (RES) and in the main vessels of the rat during shock. Pathol Res Pract 1985;179:517-27.
20. Shenep JO, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985;151: 1012-8.
21. van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W. Endotoxemia: An early predictor of septicemia in febrile patients. Lancet 1988;1:605-8.
22. Lobes J, Inniss WE. Electron microscopic effect of polymyxin on Escherichia coli lipopolysaccharide. J Bacteriol 1969;100: 1128-30.
23. Marks DH, Hou KC. Removal of bacteria from blood. Mil Med 1987;152:156-60.
24. Vijaykumar E, Raziuddin S, Wardle EN. Plasma endotoxin in patients with trauma, sepsis and severe hemorrage. Clin Intensive Care 1991;2:4-9.
25. Bysani GK, Shenep JL, Hildner WK, Stidham GL, Robertson PK. Detoxification of plasma containing lipopolysaccharide by adsorption. Crit Care Med 1990;18:67-71.